Yahoo Finance • 6 hours ago
• Tariff headlines, ‘Mag 7’ earnings, U.S. jobs report, and PCE inflation data will be in focus this week. • Meta is expected to report better-than-feared earnings due to an improving digital ad market, making it an appealing stock to buy... Full story
Yahoo Finance • 4 days ago
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly... Full story
Yahoo Finance • 4 days ago
Passive income is essential in retirement, but building a dependable stream isn't easy. Fortunately, top-tier dividend stocks can do the heavy lifting. The key is focusing on companies with strong yields, reliable payouts, and recession-re... Full story
Yahoo Finance • 4 days ago
The anti-obesity drug market has the potential to be massive, with multiple analysts projecting it may reach at least $100 billion by 2030. As a result, many top healthcare companies are vying for a piece of the market, as doing so could g... Full story
Yahoo Finance • 5 days ago
We recently published a list of 15 Recent Activist Investor Campaigns. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other recent activist investor campaigns. Economic uncertainty and market v... Full story
Yahoo Finance • 8 days ago
We recently published a list of Jeff Smith’s Top 10 Activist Targets and Their Returns Compared to the S&P 500. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other Jeff Smith’s top activist tar... Full story
Yahoo Finance • 8 days ago
It's been a tough start to 2025 for investors amid concerns regarding the strength of the U.S. economy and uncertainties over the effect of sweeping changes in trade policy under the Trump administration. At the time of writing, the S&P 50... Full story
Yahoo Finance • 12 days ago
Pfizer(NYSE: PFE) recently reminded investors how risky the drug-development business can be. On April 14, the company told investors it would scrap development of danuglipron, its oral GLP-1 candidate for weight management. The stock has... Full story
Yahoo Finance • 13 days ago
We recently published a list of 10 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other stocks on Jim Cramer’s radar. On Thursday, Mad Money host Jim Cramer cautio... Full story
Yahoo Finance • 13 days ago
Bad news for Pfizer (NYSE: PFE) turned into good news for Eli Lilly (NYSE: LLY), Novo Nordisk(NYSE: NVO), and Viking Therapeutics(NASDAQ: VKTX) Monday morning, each of which is rising on Pfizer's latest product announcement. Early this mo... Full story
Yahoo Finance • 13 days ago
We recently published a list of the 11 Best Dividend Paying Stocks According to Hedge Funds. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other best dividend-paying stocks. Dividend-paying st... Full story
Yahoo Finance • 13 days ago
Check out the companies making headlines before the bell. Goldman Sachs — The investment bank gained nearly 2% after reporting a top- and bottom-line beat in the first quarter. Goldman Sachs posted earnings of $14.12 per share while analys... Full story
Yahoo Finance • 16 days ago
We recently published a list of the 11 Cheap NYSE Stocks to Invest in According to Hedge Funds. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other cheap NYSE stocks. On March 26, Jack Caffrey... Full story
Yahoo Finance • 18 days ago
Check out the companies making headlines before the bell. Pharmaceutical stocks – Shares of U.S. companies in the pharmaceutical industry fell after President Donald Trump said late Tuesday that he's going to announce " very shortly a majo... Full story
Yahoo Finance • 19 days ago
Investing.com -- Goldman Sachs initiated coverage on several large-cap pharmaceutical companies, taking a cautious stance on Bristol-Myers Squibb (NYSE:BMY), Pfizer (NYSE:PFE), and AbbVie (NYSE:ABBV), while upgrading Eli Lilly (NYSE:LLY)... Full story
Yahoo Finance • 22 days ago
Most people don't like seeing stock prices go down. It triggers a very natural emotional response associated with pain and loss. But for long-term investors, lower share prices are a good thing. There is a famous expression that the stock... Full story
Yahoo Finance • 24 days ago
In 2020, many companies tried to develop effective coronavirus vaccines, but two ended up succeeding and dominating the field: Pfizer(NYSE: PFE) and Moderna(NASDAQ: MRNA). These two vaccine makers made small fortunes thanks to their work i... Full story
Yahoo Finance • 26 days ago
We recently published a list of 8 Most Undervalued Healthcare Stocks to Buy According to Analysts. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other most undervalued healthcare stocks to buy... Full story
Yahoo Finance • 28 days ago
We recently published a list of 11 Blue Chip Stocks to Invest in at 52-Week Lows. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other blue chip stocks to invest in at 52-week lows. For the fir... Full story
Yahoo Finance • last month
SAN DIEGO, March 25, 2025--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, today announced the appointment of Jon Coleman as chief commercial officer. In this role, Mr. Coleman will assume responsibil... Full story